Emerade epinephrine auto-injector was launched in 2014 and it is available in 10 European countries. It is the fastest growing epinephrine pen and it is the most or second most prescribed pen in several markets.
In Europe, Emerade is sold by Bausch Health. Bausch Health is the largest Canadian pharmaceutical company.
In the USA, epinephrine autoinjectors are a billion dollar market and Medeca Pharma is now looking for a partner to commercialize Emerade here.